Advertisement
help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinstein, J. L.
Right arrow Articles by Cohn, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinstein, J. L.
Right arrow Articles by Cohn, S. L.
The Oncologist, Vol. 8, No. 3, 278–292, June 2003
© 2003 AlphaMed Press

ORIGINAL PAPER
Pediatric Oncology

Advances in the Diagnosis and Treatment of Neuroblastoma

Joanna L. Weinsteina,b, Howard M. Katzensteinc,d,e, Susan L. Cohna,b

a Department of Pediatrics and b Robert H. Lurie Comprehensive Cancer Center, Northwestern University, The Feinberg School of Medicine, Chicago, Illinois, USA; c AFLAC Cancer Center, d Children’s Healthcare of Atlanta, and e Emory University, Atlanta, Georgia, USA

Correspondence: Susan L. Cohn, M.D., Children’s Memorial Hospital, Division of Hematology/Oncology, Box #30, 2300 Children’s Plaza, Chicago, Illinois 60614, USA. Telephone: 773-880-4562; Fax: 773-880-3053; e-mail: scohn{at}northwestern.edu

Neuroblastoma, a childhood neoplasm arising from neural crest cells, is characterized by a diversity of clinical behavior ranging from spontaneous remission to rapid tumor progression and death. To a large extent, outcome can be predicted by the stage of disease and the age at diagnosis. However, the molecular events responsible for the variability in response to treatment and the rate of tumor growth remain largely unknown. Over the past decade, transformation-linked genetic changes have been identified in neuroblastoma tumors that have contributed to the understanding of tumor predisposition, metastasis, treatment responsiveness, and prognosis. The Children’s Oncology Group recently developed a Neuroblastoma Risk Stratification System that is currently in use for treatment stratification purposes, based on clinical and biologic factors that are strongly predictive of outcome. This review discusses the current risk-based treatment approaches for children with neuroblastoma and recent advances in biologic therapy.

Key Words. Neuroblastoma • Tumor biology • Retinoids • Immunotherapy • Risk-based therapy




This article has been cited by other articles:


Home page
 Jpn J Clin OncolHome page
T. Nakayama, S. Asami, S.-i. Ono, M. Miura, M. Hayasaka, Y. Yoshida, M. Toriyama, S. Motohashi, and T. Suzuki
Effect of Cell Differentiation for Neuroblastoma by Vitamin K Analogs
Jpn. J. Clin. Oncol., April 1, 2009; 39(4): 251 - 259.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Salcedo, J. A. Hixon, J. K. Stauffer, R. Jalah, A. D. Brooks, T. Khan, R.-M. Dai, L. Scheetz, E. Lincoln, T. C. Back, et al.
Immunologic and Therapeutic Synergy of IL-27 and IL-2: Enhancement of T Cell Sensitization, Tumor-Specific CTL Reactivity and Complete Regression of Disseminated Neuroblastoma Metastases in the Liver and Bone Marrow
J. Immunol., April 1, 2009; 182(7): 4328 - 4338.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
M. Puppo, F. Battaglia, C. Ottaviano, S. Delfino, D. Ribatti, L. Varesio, and M. C. Bosco
Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1{alpha} and -2{alpha}
Mol. Cancer Ther., July 1, 2008; 7(7): 1974 - 1984.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
M. M. Refaat, S. Z. Idriss, and L. S. Blaszkowsky
Case Report: An Unusual Case of Adrenal Neuroblastoma in Pregnancy
Oncologist, February 1, 2008; 13(2): 152 - 156.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. Gesundheit, A. Moser, R. Or, and G. Klement
Successful Antiangiogenic Therapy for Neuroblastoma With Thalidomide
J. Clin. Oncol., November 20, 2007; 25(33): 5321 - 5324.
[Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
M. Nowicki, D. Ostalska-Nowicka, B. Kondraciuk, and B. Miskowiak
The significance of substance P in physiological and malignant haematopoiesis
J. Clin. Pathol., July 1, 2007; 60(7): 749 - 755.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
C. H. Kang, Y. T. Kim, S.-H. Jeon, S.-W. Sung, and J. H. Kim
Surgical treatment of malignant mediastinal neurogenic tumors in children
Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 725 - 730.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Toyoda, J. Yin, S. Mueller, E. Wimmer, and J. Cello
Oncolytic Treatment and Cure of Neuroblastoma by a Novel Attenuated Poliovirus in a Novel Poliovirus-Susceptible Animal Model
Cancer Res., March 15, 2007; 67(6): 2857 - 2864.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. C. Hu, M. J. Booth, G. Tripuraneni, D. Davies, S. A.A. Zaidi, M. Tamburo de Bella, M. J. Slade, S. B. Marley, M. Y.A. Gordon, R. S. Coffin, et al.
A Novel HSV-1 Virus, JS1/34.5-/47-, Purges Contaminating Breast Cancer Cells From Bone Marrow.
Clin. Cancer Res., November 15, 2006; 12(22): 6853 - 6862.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
T. Khan, J. A. Hixon, J. K. Stauffer, E. Lincoln, T. C. Back, J. Brenner, S. Lockett, K. Nagashima, D. Powell, and J. M. Wigginton
Therapeutic Modulation of Akt Activity and Antitumor Efficacy of Interleukin-12 Against Orthotopic Murine Neuroblastoma
J Natl Cancer Inst, February 1, 2006; 98(3): 190 - 202.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Otto, R. C. Barfield, W. J. Martin, R. Iyengar, W. Leung, T. Leimig, S. Chaleff, S. D. Gillies, and R. Handgretinger
Combination Immunotherapy with Clinical-Scale Enriched Human {gamma}{delta} T cells, hu14.18 Antibody, and the Immunocytokine Fc-IL7 in Disseminated Neuroblastoma
Clin. Cancer Res., December 1, 2005; 11(23): 8486 - 8491.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
R. Antony, A. Al-Rawas, and M. Irwin
Stridor in a newborn
Can. Med. Assoc. J., September 13, 2005; 173(6): 601 - 602.
[Full Text] [PDF]

Home page
 Arch Otolaryngol Head Neck SurgHome page
Pathology Quiz Case 1--Diagnosis
Arch Otolaryngol Head Neck Surg, February 1, 2005; 131(2): 174 - 175.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Salcedo, J. K. Stauffer, E. Lincoln, T. C. Back, J. A. Hixon, C. Hahn, K. Shafer-Weaver, A. Malyguine, R. Kastelein, and J. M. Wigginton
IL-27 Mediates Complete Regression of Orthotopic Primary and Metastatic Murine Neuroblastoma Tumors: Role for CD8+ T Cells
J. Immunol., December 15, 2004; 173(12): 7170 - 7182.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Korner, B. Waser, and J. C. Reubi
High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia
Clin. Cancer Res., December 15, 2004; 10(24): 8426 - 8433.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Puppo, S. Pastorino, G. Melillo, A. Pezzolo, L. Varesio, and M. C. Bosco
Induction of Apoptosis by Flavopiridol in Human Neuroblastoma Cells Is Enhanced under Hypoxia and Associated With N-myc Proto-oncogene Down-Regulation
Clin. Cancer Res., December 15, 2004; 10(24): 8704 - 8719.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
H. M. Katzenstein, S. L. Cohn, R. M. Shore, D. M.E. Bardo, P. R. Haut, M. Olszewski, J. Schmoldt, D. Liu, A. W. Rademaker, and M. Kletzel
Scintigraphic Response by 123I-Metaiodobenzylguanidine Scan Correlates With Event-Free Survival in High-Risk Neuroblastoma
J. Clin. Oncol., October 1, 2004; 22(19): 3909 - 3915.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2003 by AlphaMed Press.
Advertisement